Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥70 years with ultralow risk of distant recurrence: A population-based cohort study

被引：2
|
作者：
Mansani, Fabio P. [1 ]
Freitas-Junior, Ruffo [2 ]
机构：
[1] Univ Estadual Ponta Grossa, Ponta Grossa, PR, Brazil
[2] Univ Fed Goias, Goiania, Brazil
来源：
JOURNAL OF GERIATRIC ONCOLOGY | 2023年 / 14卷 / 05期
关键词：
Breast cancer; Endocrine therapy; Geriatric oncology; Genomic risk profile; Individualized treatment;
D O I：
10.1016/j.jgo.2023.101526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study
    Noordhoek, Iris
    Bastiaannet, Esther
    de Glas, Nienke A.
    Scheepens, Josien
    Esserman, Laura J.
    Wesseling, Jelle
    Scholten, Astrid N.
    Schroder, Carolien P.
    Elias, Sjoerd G.
    Kroep, Judith R.
    Portielje, Johanneke E. A.
    Kleijn, Miranda
    Liefers, Gerrit-Jan
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (08) : 1172 - 1177
  • [2] The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence risk in patients aged ≥70 years from the population-based observational FOCUS cohort
    Noordhoek, Iris
    Bastiaannet, Esther
    Lujinovic, Ersan
    Esserman, Laura
    Wesseling, Jelle
    Scholten, Astrid
    Schroder, Carolien P.
    Elias, Sjoerd
    de Glas, Nienke A.
    Kroep, Judith R.
    Portielje, Johanneke E. A.
    Kleijn, Miranda
    Liefers, Gerrit-Jan J.
    CANCER RESEARCH, 2021, 81 (04)
  • [3] The 70-gene MammaPrint signature for optimal risk stratification in endocrine responsive breast cancer
    Knauer, M.
    Rutgers, E.
    Mook, S.
    Cardoso, F.
    van de Vijver, M.
    Viale, G.
    Glas, A.
    Saghatchian, M.
    Kok, M.
    Bueno-de-Mesquita, J.
    Linn, S.
    van 't Veer, L.
    BREAST, 2009, 18 : S36 - S36
  • [4] French cost effectiveness study of the MammaPrint 70-gene signature in early stage breast cancer patients
    Zarca, D.
    Stork-Sloots, L.
    de Snoo, F.
    Brink, G.
    Dervaux, Y.
    Boubli, L.
    EJC SUPPLEMENTS, 2009, 7 (02): : 310 - 310
  • [5] MammaPrint™ 70-gene signature: another milestone in personalized medical care for breast cancer patients
    Slodkowska, Elzbieta A.
    Ross, Jeffrey S.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (05) : 417 - 422
  • [6] THE 70-GENE MAMMAPRINT SIGNATURE FOR RISK STRATIFICATION IN BREAST CANCER: A COMPARISON WITH TRADITIONAL PATHOLOGIC AND CLINICAL TOOLS
    Pizzutilo, Pamela
    Carandina, Ilaria
    Giuliani, Jacopo
    Carcoforo, Paolo
    Pellegrini, Francesco
    Pedriali, Massimo
    Munerato, Gardenia
    Indelli, Monica
    Querzoli, Patrizia
    Nenci, Italo
    Lelli, Giorgio
    ANNALS OF ONCOLOGY, 2009, 20
  • [7] The 70-gene signature affects adjuvant systemic treatment decisions in breast cancer patients: A population-based, observational study
    Kuijer, Anne
    van Bommel, Annelotte C. M.
    van der Heiden-van der Loo, Margriet
    Drukker, Carolien A.
    van Dalen, Thijs
    CANCER RESEARCH, 2015, 75
  • [8] Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature
    Opdam, M.
    van der Noort, V
    Kleijn, M.
    Glas, A.
    Mandjes, I
    Kleiterp, S.
    Hilbers, F. S.
    Kruger, D. T.
    Bins, A. D.
    de Jong, P. C.
    Schiphorst, P. P. J. B. M.
    van Dalen, T.
    Flameling, B.
    Rietbroek, R. C.
    Beeker, A.
    van den Heiligenberg, S. M.
    Bakker, S. D.
    Wymenga, A. N. M.
    Oving, I. M.
    Bijlsma, R. M.
    van Diest, P. J.
    Vermorken, J. B.
    van Tinteren, H.
    Linn, S. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 265 - 278
  • [9] Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature
    M. Opdam
    V. van der Noort
    M. Kleijn
    A. Glas
    I. Mandjes
    S. Kleiterp
    F. S. Hilbers
    D. T. Kruger
    A. D. Bins
    P. C. de Jong
    P. P. J. B. M. Schiphorst
    T. van Dalen
    B. Flameling
    R. C. Rietbroek
    A. Beeker
    S. M. van den Heiligenberg
    S. D. Bakker
    A. N. M. Wymenga
    I. M. Oving
    R. M. Bijlsma
    P. J. van Diest
    J. B. Vermorken
    H. van Tinteren
    S. C. Linn
    Breast Cancer Research and Treatment, 2022, 194 : 265 - 278
  • [10] The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
    Mook, S.
    Schmidt, M. K.
    Weigelt, B.
    Kreike, B.
    Eekhout, I.
    van de Vijver, M. J.
    Glas, A. M.
    Floore, A.
    Rutgers, E. J. T.
    't Veer, L. J. Van
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 717 - 722
12345